2021 | Business

Immunotherapy company creating cell-therapy manufacturing facility in Rockville

Expansion is expected to bring 175 jobs by 2023

A clinical-stage cell-therapy company will lease space at the Shady Grove Life Sciences Center in Rockville and hire 175 employees in the next two years, Montgomery County’s economic development organization said.

TCR2 Therapeutics will build out a facility at 9500 Medical Center Drive as it works toward production in 2023, according to the Montgomery County Economic Development Corporation (MCEDC).

The expansion will support the company’s clinical and commercial production of gavo-cel, a cell therapy, “with a capacity to treat several thousand cancer patients annually,” an MCEDC release says.

TCR2 Therapeutics will lease an existing 85,000-square-foot cell-therapy manufacturing facility under an agreement with Alexandria Real Estate Equities. The space will be used for commercial and clinical manufacturing, quality-control laboratories and offices.

The Maryland Department of Commerce approved an $875,000 loan, and the county approved a $100,000 grant to help with project costs related to the expansion. In both cases, the money is contingent on job creation and capital investment, according to the press release.

Garry Menzel, the president and CEO of TCR2 Therapeutics, said in the press release that “leasing an existing manufacturing footprint is a substantial milestone” for the company and will save “valuable time and capital.”

“Our new state-of-the-art facility will allow us to directly leverage our cell therapy process development expertise and control our end-to-end production supply chain,” he said. “We are very pleased to be building a world-class cell therapy production facility for gavo-cel that will bring new hope to cancer patients suffering from solid tumors.”